Chest ACCP Career Connection
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Guest Access | Sign In via User Name/Password
This Article
Right arrow Full Text (PDF) Free
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Article Archive
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hoffman, I. B.
Right arrow Articles by Fiel, S. B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hoffman, I. B.
Right arrow Articles by Fiel, S. B.
(Chest. 1988;93:11-13.)
© 1988 American College of Chest Physicians

Oral vs Repository Corticosteroid Therapy in Acute Asthma

Ian B. Hoffman M.D.1 and Stanley B. Fiel M.D., F.C.C.P.1

1 From the Pulmonary Disease Section, Temple University Hospital, Philadelphia

Acutely ill asthmatic patients treated in the usual fashion in an emergency room setting and discharged within six hours were studied to determine whether therapy with a single injection of a repository corticosteroid (methylprednisolone sodium acetate) could be as effective as a tapering course of oral corticosteroids in decreasing asthma symptomatology and relapse within seven days. Seventeen patients (18 episodes of asthma) formed the study population. Eight episodes occurred in patients who received depot methylprednisolone (group 1) and ten episodes in patients who received oral corticosteroid treatment (group 2). All patients in both groups improved following emergency room treatment. Relapse occurred in two of ten patients in group 2 and none in group 1. Symptoms attributable to asthma recurred in significantly more patients in group 2 than in group 1(9 vs 0, p<.0l). Side effects from therapy with corticosteroids were rare. This study indicates that intramuscular repository corticosteroids are at least as effective as oral corticosteroids in the management of the acute asthmatic outpatient, with a distinct advantage with regard to patient compliance.

Submitted on January 22, 2007
Accepted on July 9, 2007




This article has been cited by other articles:


Home page
 ChestHome page
M. Lahn, P. Bijur, and E. J. Gallagher
Randomized Clinical Trial of Intramuscular vs Oral Methylprednisolone in the Treatment of Asthma Exacerbations Following Discharge From an Emergency Department
Chest, August 1, 2004; 126(2): 362 - 368.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
E. R. McFadden Jr.
Acute Severe Asthma
Am. J. Respir. Crit. Care Med., October 1, 2003; 168(7): 740 - 759.
[Abstract] [Full Text] [PDF]

Home page
 CLIN PEDIATRHome page
B. E. Chipps and D. R. Chipps
A Review of the Role of Inhaled Corticosteroids in the Treatment of Acute Asthma
Clinical Pediatrics, April 1, 2001; 40(4): 185 - 189.
[Abstract] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1988 by the American College of Chest Physicians.